-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $16

Benzinga·12/04/2025 12:02:53
语音播报
Needham analyst Gil Blum initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy rating and announces Price Target of $16.